Under the influence of the epidemic, what are the impacts of the medicinal glass bottle industry?

At present, due to the shortage of vaccine glass bottles, medicinal glass has quickly entered the public eye. As a small branch of the pharmaceutical industry, medicinal glass bottles play an important role in improving the shelf life of drugs, and their quality is directly related to the safety and stability of drugs.

According to the Reportlinker report, the global pharmaceutical glass market will reach US$22.05 billion in 2025, with a compound annual growth rate of 6.4% during the forecast period. my country is a big country in pharmaceutical production. In 2018, the market size of the pharmaceutical packaging industry reached 106.8 billion yuan, an increase of 10.6% over the previous year. The market size of pharmaceutical glass in 2018 reached 21.94 billion yuan, accounting for about 20% of the pharmaceutical packaging industry.

With the improvement of people's living standards and health concepts, more and more attention has been paid to the medical and health industry, and the market potential of medicinal glass is favored by the industry. It is understood that there are currently more than 60 companies engaged in pharmaceutical glass packaging in China.

Puyang Shixuan medical glass bottle manufacturer is mainly engaged in the research and development, production and sales of various medicinal glass packaging products, including molded bottles, brown bottles, ampoules, control bottles, butyl rubber stoppers, plastic bottles with aluminum plastic caps, etc. Six major series. The company's molded bottles account for over 80% of the market.

The company's performance report for the first quarter of 2020 shows that from January to March, the company achieved operating income of 145 million yuan, down 13.32% year-on-year; net profit was 18.99 million yuan, down 18.67% year-on-year.

Recently, related companies have also received the attention of investors. For example, on May 29, Kibing Group stated on the interactive platform that the company is constructing a neutral borosilicate medicinal glass project. After the completion of the project, its products can be used for biological products, blood products, freeze-dried preparations, vaccines and other drugs. package.

The author learned that the company’s recently released "Announcement on Joint Investment in the Construction of Neutral Borosilicate Glass Tube Project and Related Transactions" shows that the company intends to invest in the neutral borosilicate glass project. The project is planned to be constructed in phases. The scale is 3 kilns and 8 lines 100 tons/day (kiln output) neutral borosilicate medicinal glass tube, as well as product deep processing. The total investment of the project is about 600 million yuan. This time, it is planned to invest in the first phase of the neutral borosilicate medicinal glass tube project in Zixing City, Chenzhou City, Hunan Province. The total planned investment of this phase of the project is 155 million yuan, of which 100 million yuan is self-raised and the remaining 55.28 million yuan applies for loans. solve.

On the same day, Deli stated on the interactive platform that the company communicated and explored in the field of related glass materials. Earlier, there were reports that the company has accelerated its exploration in new fields such as neutral medicinal glass, optical glass, and industrial glass, and exerted its influence in the industry at home and abroad, and actively introduced new technologies, materials and The craftsmanship laid the foundation for Deli to enter the field of high-end glass materials.

On May 15th, Ancai Hi-Tech replied on the interactive platform that, as of now, the company's shareholding company Kaisheng Ancai Junheng has not actually started the construction of the neutral borosilicate medicinal glass project.

In addition, Jianye replied to investors on the 14th that the company's n-butylamine products are mainly used as intermediates for dyes, medicines, and pesticides. Currently, there is no information applied to the field of pharmaceutical glass packaging.

For more knowledge about medicinal glass bottles, pay attention to Puyang Shixuan Glass Products Co., Ltd., which is a large-scale production base specialized in the production of medicinal glass bottles certified by the State Food and Drug Administration. Now our company has established cooperative relations with more than 100 outstanding domestic pharmaceutical companies, and exported to India, Indonesia, the Philippines, Iran, Vietnam, South Korea, Russia, Turkey and other countries. The product quality has been well received by customers.